COVID-19 Pandemic (Coronavirus)

null

...
Joined
Nov 12, 2014
Messages
30,518
Reputation
5,307
Daps
48,271
Reppin
UK, DE, GY, DMV
NIH ADMITS to funding gain-of-function research on bat coronaviruses at China's Wuhan lab despite Dr. Fauci repeatedly insisting to Congress that it did not happen
  • In a new letter, NIH's principal deputy director Lawrence A. Tabak says lab rats were infected with the modified bat virus in the Wuhan lab in China
  • While never using the term, Tabak essentially confirms that gain of function research, took place despite consistent denials from Dr. Fauci
  • In May, Fauci testified that the NIH 'has not ever and does not now fund gain of function research in the Wuhan Institute of Virology'
  • The letter shifts the blame to U.S non profit EcoHealth Alliance for not being transparent about the kind of research they were doing
  • Senator Rand Paul, who was widely mocked for promoting the lab leak theory, tweeted the letter, writing: 'I told you so' doesn't even begin to cover it here'
The National Institutes of Health has finally admitted to funding gain of function research on bat coronaviruses in it's Wuhan laboratory despite Dr. Fauci's denials to congress that no such research took place.

The admission came in a letter addressed Kentucky congressman James Comer on Wednesday, in which NIH's principal deputy director Lawrence A. Tabak refers to a 'limited experiment' conducted to test if 'spike proteins from naturally occurring bat coronaviruses circulating in China were capable of binding to the human ACE2 receptor in a mouse model,' at the Wuhan lab.

According to Tabak, the mice infected with the modified bat virus 'became sicker' than those infected with the unmodified bat virus.



@skylove4
@Chronic

remember ...
 

Sinnerman

Veteran
Joined
May 7, 2012
Messages
32,629
Reputation
4,436
Daps
64,945


"and if you want to move on this merry go round" :wow:

------

Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine

  • First results from any randomized, controlled COVID-19 vaccine booster trial demonstrate a relative vaccine efficacy of 95.6% against disease during a period when Delta was the prevalent strain
  • In trial with more than 10,000 participants 16 years of age and older, COVID-19 booster was found to have a favorable safety profile
  • Companies plan to submit these data to FDA, EMA and other regulatory agencies to further support licensure in the U.S. and other countries
NEW YORK and MAINZ, GERMANY, October 21, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more than 10,000 individuals 16 years of age and older. In the trial, a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series restored vaccine protection against COVID-19 to the high levels achieved after the second dose, showing a relative vaccine efficacy of 95.6% when compared to those who did not receive a booster. These are the first efficacy results from any randomized, controlled COVID-19 vaccine booster trial.

“These results provide further evidence of the benefits of boosters as we aim to keep people well-protected against this disease,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “In addition to our efforts to increase global access and uptake among the unvaccinated, we believe boosters have a critical role to play in addressing the ongoing public health threat of this pandemic. We look forward to sharing these data with health authorities and working together to determine how they can be used to support the rollout of booster doses around the world.”

“These important data add to the body of evidence suggesting that a booster dose of our vaccine can help protect a broad population of people from this virus and its variants,” said Ugur Sahin, M.D., CEO and Co-Founder of BioNTech. “Based on these findings we believe that, in addition to broad global access to vaccines for everyone, booster vaccinations could play an important role in sustaining pandemic containment and a return to normalcy.”

All trial participants previously completed the primary two-dose series of the Pfizer-BioNTech vaccine, and then were randomized 1:1 to receive either a 30-µg booster dose (the same dosage strength as those in the primary series) or placebo. The median time between second dose and administration of the booster dose or placebo was approximately 11 months. Symptomatic COVID-19 occurrence was measured from at least 7 days after booster or placebo, with a median follow-up of 2.5 months. During the study period, there were 5 cases of COVID-19 in the boosted group, and 109 cases in the non-boosted group. The observed relative vaccine efficacy of 95.6% (95% CI: 89.3, 98.6) reflects the reduction in disease occurrence in the boosted group versus the non-boosted group in those without evidence of prior SARS-CoV-2 infection. Median age of participants was 53 years, with 55.5% of participants between 16 and 55 years, and 23.3% of participants 65 years and older. Multiple subgroup analyses showed efficacy was consistent irrespective of age, sex, race, ethnicity, or comorbid conditions.

The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no safety concerns identified.

Pfizer and BioNTech plan to submit detailed results from the trial for peer-reviewed publication. The companies also plan to share these data with the U.S. Food and Drug Administration, European Medicines Agency, and other regulatory agencies around the world as soon as possible.

https://investors.biontech.de/news-...tech-announce-phase-3-trial-data-showing-high
 

null

...
Joined
Nov 12, 2014
Messages
30,518
Reputation
5,307
Daps
48,271
Reppin
UK, DE, GY, DMV
XFxQiiFl.png


"Boris Johnson last night piled pressure on his scientific advisers to cut the waiting time for booster jabs from six months to five.

If a decision is made immediately, nearly 9 million more Britons will become eligible for a third dose of the vaccine.

Concern has been growing that the rollout of the Covid booster scheme has been far too slow, putting the public at risk as cases rise. At present, over-50s and those with health problems are invited for their jab six months after their second dose."


Boris Johnson urges experts to cut six-month wait for third Covid vaccine | Daily Mail Online

"but but but ... israeli data is flawed ... and faneto!!!"
 

the cac mamba

Veteran
Joined
May 21, 2012
Messages
103,484
Reputation
13,823
Daps
301,616
Reppin
NULL
Covid done tbh
You're an idiot and terribly naive if you believe this. Last time y'all was on this bullshyt there was a surge which was due to Delta.
if you want to hide in your house and wear a mask for the next 5 years, you're free to do that. the rest of us will not be :yeshrug:

im fully vaccinated, and moving on with my life. that was always the deal; that was what we were told. 19 months has been FAR too much of this bullshyt
 

Malcolmxxx_23

Let's go panthers
Supporter
Joined
May 1, 2012
Messages
107,192
Reputation
-14,228
Daps
324,308
if you want to hide in your house and wear a mask for the next 5 years, you're free to do that. the rest of us will not be :yeshrug:

im fully vaccinated, and moving on with my life. that was always the deal; that was what we were told. 19 months has been FAR too much of this bullshyt
Its been normal here..even strict ass canada
No more living in fear

Heading to a party in 25min
We waiting for our uber
We vaxxed up..covid is done

My fit tonight:blessed:


Fred
 
Joined
Dec 14, 2015
Messages
18,081
Reputation
4,409
Daps
39,981
Reppin
404/678/770 тσ 702
if you want to hide in your house and wear a mask for the next 5 years, you're free to do that. the rest of us will not be :yeshrug:

im fully vaccinated, and moving on with my life. that was always the deal; that was what we were told. 19 months has been FAR too much of this bullshyt

Personally, I'on give a fukk what you or anyone else does. That's your business, not my concern.
 

Absolut

Legal Bookie
Joined
Apr 30, 2012
Messages
15,740
Reputation
621
Daps
55,545
Reppin
Las Vegas
Personally, I'on give a fukk what you or anyone else does. That's your business, not my concern.
Precisely. Most folks will move on. Those that don’t want to don’t need to project their fears and restrictions on the masses. Stay home if you want. That shouldn’t impact what anyone else is free to do. There’s no reason for mandates and restrictions to exist at this stage to kowtow to folks still wanting to continue living in isolation. Vaccines exist. Robust data shows they are incredibly effective vs all variants. A third shot provides even wider safety if you want it. Sit in solitude and watch the world go by. Sounds like fun
 
Top